References
- Lloyd-Jones D, Adams R, Carnethon M et al. For the American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistis-2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation119(3), e21–e181 (2009).
- Papaioannou A, Morin S, Cheung AM et al. For the Scientific advisory council of osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ182(17), 1864–1873 (2010).
- Carbone L, Buzkova P, Fink HA et al. Hip fractures and heart failure: findings from the cardiovascular health study. Eur. Heart J.31(1), 77–84 (2010).
- Majumdar SR, Ezekowitz JA, Lix LM, Leslie LM. Heart failure is a clinically and densitometrically independent and novel risk factor for major osteoporotic fractures: population-based cohort of 45509 subjects. J. Bone Miner. Res.26(Suppl. 1), S10 (2011).
- Van Diepen S, Majumdar SR, Bakal JA, McAlister FA, Ezekowitz JA. Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16294 patients. Circulation118(19), 1946–1952 (2008).
- Lyons K, Majumdar SR, Ezekowitz JA. The unrecognized burden of osteoporosis-related vertebral fractures in patients with heart failure. Circ. Heart Fail.4(1), 419–424 (2011).
- Shane E, Mancini D, Aaronson K et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am. J. Med.103(3), 197–207 (1997).
- Sennerby U, Melhus H, Gedeborg R et al. Cardiovascular diseases and risk of hip fracture. JAMA302(15), 1666–1673 (2009).
- Gerber Y, Melton LJ, Weston SA, Roger VL. Osteoporotic fractures and heart failure in the community. Am. J. Med.124(5), 418–425 (2011).
- Rolland Y, Abellan Van Kan G, Benetos A et al. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J. Nutr. Health Aging12(5), 335–346 (2008).
- Newman AB, Gottdiener JS, McBurnie MA et al. Associations of subclinical cardiovascular disease with frailty. J. Gerontol. A. Biol. Med. Sci.56(3), M156–M166 (2001).
- Lim LS, Fink HA, Kuskowski MA et al. Loop diuretic use and increased rates of hip bone loss in older men: the osteoporotic fractures in men study. Arch. Intern. Med.168(7), 735–740 (2008).
- Wiens M, Etminan M, Gill SS, Takkouche B. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observation studies. J. Intern. Med.260(4), 350–362 (2006).
- Rejnmark L, Vestergaard P, Mosekilde L. Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J. Bone Miner. Res.21(11), 1811–1817 (2006).
- Carbone LD, Cross JD, Raza SH et al. Fracture risk in men with congestive heart failure: Risk reduction with spironolactone. 52(2), 135–138 (2008).
- Pilz S, Tomaschitz A. Vitamin D status: to be considered in heart failure patients! Eur. J. Heart Fail.13(6), 595–596 (2011).
- Barasch E, Gottdiener JS, Aurigemma G et al. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ. Heart Fail.2(4), 202–310 (2009).
- Chhokar VS, Sun Y, Bhattacharya SK et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation111(7), 871–878 (2005).
- Maclean C, Newberry S, Maglione M et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann. Intern. Med.148(3), 197–213 (2008).